Plain-English translation of NCT06072703 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called repetitive transcranial magnetic stimulation (rTMS)—a noninvasive way to stimulate specific regions of your brain—to help reduce bladder symptoms like urgency, frequency, and incontinence in women with multiple sclerosis. Instead of focusing on treating the bladder itself, this approach targets brain regions that control bladder function. Early results in a small group of women showed significant improvement in bladder symptoms without serious side effects.
Many people with multiple sclerosis experience overactive bladder symptoms that are difficult to manage with current treatments, which often have unwanted side effects or limited effectiveness. This trial explores a new approach that works at the brain level rather than the bladder level, offering hope for a better, less invasive option.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either active brain stimulation or a sham (placebo) version that looks identical. Your treatment will consist of sessions conducted five days a week for two weeks, with each session lasting 40 minutes. During the sessions, a magnetic coil will be placed against your scalp to deliver the stimulation. The study uses special imaging to precisely target the brain regions involved in bladder control. After the two-week treatment period, you will return for follow-up visits to assess whether your bladder symptoms have improved.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States